Global Immune Drugs Market Research Report 2024(Status and Outlook)
Report Overview
This report provides a deep insight into the global Immune Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Immune Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Immune Drugs market in any manner.
Global Immune Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Antares Pharma, Inc.
UCB
Incyte
GSK
Takeda
3S Bio
Horizon Therapeutics
Bristol-Myers Squibb (BMS
Astellas
Eli Lilly
Mitsubishi Tanabe Pharma
Biogen
Pfizer
Sanofi
Roche
Novartis
Johnson & Johnson (J&J)
Amgen
Abbvi
Market Segmentation (by Type)
Immune Boosting Drugs
Immunosuppressant Drugs
Market Segmentation (by Application)
Hospital
Clinic
Surgery Center
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Immune Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
This report provides a deep insight into the global Immune Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Immune Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Immune Drugs market in any manner.
Global Immune Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Antares Pharma, Inc.
UCB
Incyte
GSK
Takeda
3S Bio
Horizon Therapeutics
Bristol-Myers Squibb (BMS
Astellas
Eli Lilly
Mitsubishi Tanabe Pharma
Biogen
Pfizer
Sanofi
Roche
Novartis
Johnson & Johnson (J&J)
Amgen
Abbvi
Market Segmentation (by Type)
Immune Boosting Drugs
Immunosuppressant Drugs
Market Segmentation (by Application)
Hospital
Clinic
Surgery Center
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Immune Drugs Market
- Overview of the regional outlook of the Immune Drugs Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Immune Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Immune Drugs
1.2 Key Market Segments
1.2.1 Immune Drugs Segment by Type
1.2.2 Immune Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 IMMUNE DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Immune Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Immune Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 IMMUNE DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Global Immune Drugs Sales by Manufacturers (2019-2024)
3.2 Global Immune Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Immune Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Immune Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Immune Drugs Sales Sites, Area Served, Product Type
3.6 Immune Drugs Market Competitive Situation and Trends
3.6.1 Immune Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Immune Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 IMMUNE DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Immune Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF IMMUNE DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 IMMUNE DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Immune Drugs Sales Market Share by Type (2019-2024)
6.3 Global Immune Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Immune Drugs Price by Type (2019-2024)
7 IMMUNE DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Immune Drugs Market Sales by Application (2019-2024)
7.3 Global Immune Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Immune Drugs Sales Growth Rate by Application (2019-2024)
8 IMMUNE DRUGS MARKET SEGMENTATION BY REGION
8.1 Global Immune Drugs Sales by Region
8.1.1 Global Immune Drugs Sales by Region
8.1.2 Global Immune Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Immune Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Immune Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Immune Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Immune Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Immune Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Antares Pharma, Inc.
9.1.1 Antares Pharma, Inc. Immune Drugs Basic Information
9.1.2 Antares Pharma, Inc. Immune Drugs Product Overview
9.1.3 Antares Pharma, Inc. Immune Drugs Product Market Performance
9.1.4 Antares Pharma, Inc. Business Overview
9.1.5 Antares Pharma, Inc. Immune Drugs SWOT Analysis
9.1.6 Antares Pharma, Inc. Recent Developments
9.2 UCB
9.2.1 UCB Immune Drugs Basic Information
9.2.2 UCB Immune Drugs Product Overview
9.2.3 UCB Immune Drugs Product Market Performance
9.2.4 UCB Business Overview
9.2.5 UCB Immune Drugs SWOT Analysis
9.2.6 UCB Recent Developments
9.3 Incyte
9.3.1 Incyte Immune Drugs Basic Information
9.3.2 Incyte Immune Drugs Product Overview
9.3.3 Incyte Immune Drugs Product Market Performance
9.3.4 Incyte Immune Drugs SWOT Analysis
9.3.5 Incyte Business Overview
9.3.6 Incyte Recent Developments
9.4 GSK
9.4.1 GSK Immune Drugs Basic Information
9.4.2 GSK Immune Drugs Product Overview
9.4.3 GSK Immune Drugs Product Market Performance
9.4.4 GSK Business Overview
9.4.5 GSK Recent Developments
9.5 Takeda
9.5.1 Takeda Immune Drugs Basic Information
9.5.2 Takeda Immune Drugs Product Overview
9.5.3 Takeda Immune Drugs Product Market Performance
9.5.4 Takeda Business Overview
9.5.5 Takeda Recent Developments
9.6 3S Bio
9.6.1 3S Bio Immune Drugs Basic Information
9.6.2 3S Bio Immune Drugs Product Overview
9.6.3 3S Bio Immune Drugs Product Market Performance
9.6.4 3S Bio Business Overview
9.6.5 3S Bio Recent Developments
9.7 Horizon Therapeutics
9.7.1 Horizon Therapeutics Immune Drugs Basic Information
9.7.2 Horizon Therapeutics Immune Drugs Product Overview
9.7.3 Horizon Therapeutics Immune Drugs Product Market Performance
9.7.4 Horizon Therapeutics Business Overview
9.7.5 Horizon Therapeutics Recent Developments
9.8 Bristol-Myers Squibb (BMS
9.8.1 Bristol-Myers Squibb (BMS Immune Drugs Basic Information
9.8.2 Bristol-Myers Squibb (BMS Immune Drugs Product Overview
9.8.3 Bristol-Myers Squibb (BMS Immune Drugs Product Market Performance
9.8.4 Bristol-Myers Squibb (BMS Business Overview
9.8.5 Bristol-Myers Squibb (BMS Recent Developments
9.9 Astellas
9.9.1 Astellas Immune Drugs Basic Information
9.9.2 Astellas Immune Drugs Product Overview
9.9.3 Astellas Immune Drugs Product Market Performance
9.9.4 Astellas Business Overview
9.9.5 Astellas Recent Developments
9.10 Eli Lilly
9.10.1 Eli Lilly Immune Drugs Basic Information
9.10.2 Eli Lilly Immune Drugs Product Overview
9.10.3 Eli Lilly Immune Drugs Product Market Performance
9.10.4 Eli Lilly Business Overview
9.10.5 Eli Lilly Recent Developments
9.11 Mitsubishi Tanabe Pharma
9.11.1 Mitsubishi Tanabe Pharma Immune Drugs Basic Information
9.11.2 Mitsubishi Tanabe Pharma Immune Drugs Product Overview
9.11.3 Mitsubishi Tanabe Pharma Immune Drugs Product Market Performance
9.11.4 Mitsubishi Tanabe Pharma Business Overview
9.11.5 Mitsubishi Tanabe Pharma Recent Developments
9.12 Biogen
9.12.1 Biogen Immune Drugs Basic Information
9.12.2 Biogen Immune Drugs Product Overview
9.12.3 Biogen Immune Drugs Product Market Performance
9.12.4 Biogen Business Overview
9.12.5 Biogen Recent Developments
9.13 Pfizer
9.13.1 Pfizer Immune Drugs Basic Information
9.13.2 Pfizer Immune Drugs Product Overview
9.13.3 Pfizer Immune Drugs Product Market Performance
9.13.4 Pfizer Business Overview
9.13.5 Pfizer Recent Developments
9.14 Sanofi
9.14.1 Sanofi Immune Drugs Basic Information
9.14.2 Sanofi Immune Drugs Product Overview
9.14.3 Sanofi Immune Drugs Product Market Performance
9.14.4 Sanofi Business Overview
9.14.5 Sanofi Recent Developments
9.15 Roche
9.15.1 Roche Immune Drugs Basic Information
9.15.2 Roche Immune Drugs Product Overview
9.15.3 Roche Immune Drugs Product Market Performance
9.15.4 Roche Business Overview
9.15.5 Roche Recent Developments
9.16 Novartis
9.16.1 Novartis Immune Drugs Basic Information
9.16.2 Novartis Immune Drugs Product Overview
9.16.3 Novartis Immune Drugs Product Market Performance
9.16.4 Novartis Business Overview
9.16.5 Novartis Recent Developments
9.17 Johnson and Johnson (JandJ)
9.17.1 Johnson and Johnson (JandJ) Immune Drugs Basic Information
9.17.2 Johnson and Johnson (JandJ) Immune Drugs Product Overview
9.17.3 Johnson and Johnson (JandJ) Immune Drugs Product Market Performance
9.17.4 Johnson and Johnson (JandJ) Business Overview
9.17.5 Johnson and Johnson (JandJ) Recent Developments
9.18 Amgen
9.18.1 Amgen Immune Drugs Basic Information
9.18.2 Amgen Immune Drugs Product Overview
9.18.3 Amgen Immune Drugs Product Market Performance
9.18.4 Amgen Business Overview
9.18.5 Amgen Recent Developments
9.19 Abbvi
9.19.1 Abbvi Immune Drugs Basic Information
9.19.2 Abbvi Immune Drugs Product Overview
9.19.3 Abbvi Immune Drugs Product Market Performance
9.19.4 Abbvi Business Overview
9.19.5 Abbvi Recent Developments
10 IMMUNE DRUGS MARKET FORECAST BY REGION
10.1 Global Immune Drugs Market Size Forecast
10.2 Global Immune Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Immune Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Immune Drugs Market Size Forecast by Region
10.2.4 South America Immune Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Immune Drugs by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Immune Drugs Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Immune Drugs by Type (2025-2030)
11.1.2 Global Immune Drugs Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Immune Drugs by Type (2025-2030)
11.2 Global Immune Drugs Market Forecast by Application (2025-2030)
11.2.1 Global Immune Drugs Sales (Kilotons) Forecast by Application
11.2.2 Global Immune Drugs Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Immune Drugs
1.2 Key Market Segments
1.2.1 Immune Drugs Segment by Type
1.2.2 Immune Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 IMMUNE DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Immune Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Immune Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 IMMUNE DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Global Immune Drugs Sales by Manufacturers (2019-2024)
3.2 Global Immune Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Immune Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Immune Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Immune Drugs Sales Sites, Area Served, Product Type
3.6 Immune Drugs Market Competitive Situation and Trends
3.6.1 Immune Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Immune Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 IMMUNE DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Immune Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF IMMUNE DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 IMMUNE DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Immune Drugs Sales Market Share by Type (2019-2024)
6.3 Global Immune Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Immune Drugs Price by Type (2019-2024)
7 IMMUNE DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Immune Drugs Market Sales by Application (2019-2024)
7.3 Global Immune Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Immune Drugs Sales Growth Rate by Application (2019-2024)
8 IMMUNE DRUGS MARKET SEGMENTATION BY REGION
8.1 Global Immune Drugs Sales by Region
8.1.1 Global Immune Drugs Sales by Region
8.1.2 Global Immune Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Immune Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Immune Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Immune Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Immune Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Immune Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Antares Pharma, Inc.
9.1.1 Antares Pharma, Inc. Immune Drugs Basic Information
9.1.2 Antares Pharma, Inc. Immune Drugs Product Overview
9.1.3 Antares Pharma, Inc. Immune Drugs Product Market Performance
9.1.4 Antares Pharma, Inc. Business Overview
9.1.5 Antares Pharma, Inc. Immune Drugs SWOT Analysis
9.1.6 Antares Pharma, Inc. Recent Developments
9.2 UCB
9.2.1 UCB Immune Drugs Basic Information
9.2.2 UCB Immune Drugs Product Overview
9.2.3 UCB Immune Drugs Product Market Performance
9.2.4 UCB Business Overview
9.2.5 UCB Immune Drugs SWOT Analysis
9.2.6 UCB Recent Developments
9.3 Incyte
9.3.1 Incyte Immune Drugs Basic Information
9.3.2 Incyte Immune Drugs Product Overview
9.3.3 Incyte Immune Drugs Product Market Performance
9.3.4 Incyte Immune Drugs SWOT Analysis
9.3.5 Incyte Business Overview
9.3.6 Incyte Recent Developments
9.4 GSK
9.4.1 GSK Immune Drugs Basic Information
9.4.2 GSK Immune Drugs Product Overview
9.4.3 GSK Immune Drugs Product Market Performance
9.4.4 GSK Business Overview
9.4.5 GSK Recent Developments
9.5 Takeda
9.5.1 Takeda Immune Drugs Basic Information
9.5.2 Takeda Immune Drugs Product Overview
9.5.3 Takeda Immune Drugs Product Market Performance
9.5.4 Takeda Business Overview
9.5.5 Takeda Recent Developments
9.6 3S Bio
9.6.1 3S Bio Immune Drugs Basic Information
9.6.2 3S Bio Immune Drugs Product Overview
9.6.3 3S Bio Immune Drugs Product Market Performance
9.6.4 3S Bio Business Overview
9.6.5 3S Bio Recent Developments
9.7 Horizon Therapeutics
9.7.1 Horizon Therapeutics Immune Drugs Basic Information
9.7.2 Horizon Therapeutics Immune Drugs Product Overview
9.7.3 Horizon Therapeutics Immune Drugs Product Market Performance
9.7.4 Horizon Therapeutics Business Overview
9.7.5 Horizon Therapeutics Recent Developments
9.8 Bristol-Myers Squibb (BMS
9.8.1 Bristol-Myers Squibb (BMS Immune Drugs Basic Information
9.8.2 Bristol-Myers Squibb (BMS Immune Drugs Product Overview
9.8.3 Bristol-Myers Squibb (BMS Immune Drugs Product Market Performance
9.8.4 Bristol-Myers Squibb (BMS Business Overview
9.8.5 Bristol-Myers Squibb (BMS Recent Developments
9.9 Astellas
9.9.1 Astellas Immune Drugs Basic Information
9.9.2 Astellas Immune Drugs Product Overview
9.9.3 Astellas Immune Drugs Product Market Performance
9.9.4 Astellas Business Overview
9.9.5 Astellas Recent Developments
9.10 Eli Lilly
9.10.1 Eli Lilly Immune Drugs Basic Information
9.10.2 Eli Lilly Immune Drugs Product Overview
9.10.3 Eli Lilly Immune Drugs Product Market Performance
9.10.4 Eli Lilly Business Overview
9.10.5 Eli Lilly Recent Developments
9.11 Mitsubishi Tanabe Pharma
9.11.1 Mitsubishi Tanabe Pharma Immune Drugs Basic Information
9.11.2 Mitsubishi Tanabe Pharma Immune Drugs Product Overview
9.11.3 Mitsubishi Tanabe Pharma Immune Drugs Product Market Performance
9.11.4 Mitsubishi Tanabe Pharma Business Overview
9.11.5 Mitsubishi Tanabe Pharma Recent Developments
9.12 Biogen
9.12.1 Biogen Immune Drugs Basic Information
9.12.2 Biogen Immune Drugs Product Overview
9.12.3 Biogen Immune Drugs Product Market Performance
9.12.4 Biogen Business Overview
9.12.5 Biogen Recent Developments
9.13 Pfizer
9.13.1 Pfizer Immune Drugs Basic Information
9.13.2 Pfizer Immune Drugs Product Overview
9.13.3 Pfizer Immune Drugs Product Market Performance
9.13.4 Pfizer Business Overview
9.13.5 Pfizer Recent Developments
9.14 Sanofi
9.14.1 Sanofi Immune Drugs Basic Information
9.14.2 Sanofi Immune Drugs Product Overview
9.14.3 Sanofi Immune Drugs Product Market Performance
9.14.4 Sanofi Business Overview
9.14.5 Sanofi Recent Developments
9.15 Roche
9.15.1 Roche Immune Drugs Basic Information
9.15.2 Roche Immune Drugs Product Overview
9.15.3 Roche Immune Drugs Product Market Performance
9.15.4 Roche Business Overview
9.15.5 Roche Recent Developments
9.16 Novartis
9.16.1 Novartis Immune Drugs Basic Information
9.16.2 Novartis Immune Drugs Product Overview
9.16.3 Novartis Immune Drugs Product Market Performance
9.16.4 Novartis Business Overview
9.16.5 Novartis Recent Developments
9.17 Johnson and Johnson (JandJ)
9.17.1 Johnson and Johnson (JandJ) Immune Drugs Basic Information
9.17.2 Johnson and Johnson (JandJ) Immune Drugs Product Overview
9.17.3 Johnson and Johnson (JandJ) Immune Drugs Product Market Performance
9.17.4 Johnson and Johnson (JandJ) Business Overview
9.17.5 Johnson and Johnson (JandJ) Recent Developments
9.18 Amgen
9.18.1 Amgen Immune Drugs Basic Information
9.18.2 Amgen Immune Drugs Product Overview
9.18.3 Amgen Immune Drugs Product Market Performance
9.18.4 Amgen Business Overview
9.18.5 Amgen Recent Developments
9.19 Abbvi
9.19.1 Abbvi Immune Drugs Basic Information
9.19.2 Abbvi Immune Drugs Product Overview
9.19.3 Abbvi Immune Drugs Product Market Performance
9.19.4 Abbvi Business Overview
9.19.5 Abbvi Recent Developments
10 IMMUNE DRUGS MARKET FORECAST BY REGION
10.1 Global Immune Drugs Market Size Forecast
10.2 Global Immune Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Immune Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Immune Drugs Market Size Forecast by Region
10.2.4 South America Immune Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Immune Drugs by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Immune Drugs Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Immune Drugs by Type (2025-2030)
11.1.2 Global Immune Drugs Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Immune Drugs by Type (2025-2030)
11.2 Global Immune Drugs Market Forecast by Application (2025-2030)
11.2.1 Global Immune Drugs Sales (Kilotons) Forecast by Application
11.2.2 Global Immune Drugs Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Immune Drugs Market Size Comparison by Region (M USD)
Table 5. Global Immune Drugs Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Immune Drugs Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Immune Drugs Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Immune Drugs Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immune Drugs as of 2022)
Table 10. Global Market Immune Drugs Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Immune Drugs Sales Sites and Area Served
Table 12. Manufacturers Immune Drugs Product Type
Table 13. Global Immune Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Immune Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Immune Drugs Market Challenges
Table 22. Global Immune Drugs Sales by Type (Kilotons)
Table 23. Global Immune Drugs Market Size by Type (M USD)
Table 24. Global Immune Drugs Sales (Kilotons) by Type (2019-2024)
Table 25. Global Immune Drugs Sales Market Share by Type (2019-2024)
Table 26. Global Immune Drugs Market Size (M USD) by Type (2019-2024)
Table 27. Global Immune Drugs Market Size Share by Type (2019-2024)
Table 28. Global Immune Drugs Price (USD/Ton) by Type (2019-2024)
Table 29. Global Immune Drugs Sales (Kilotons) by Application
Table 30. Global Immune Drugs Market Size by Application
Table 31. Global Immune Drugs Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Immune Drugs Sales Market Share by Application (2019-2024)
Table 33. Global Immune Drugs Sales by Application (2019-2024) & (M USD)
Table 34. Global Immune Drugs Market Share by Application (2019-2024)
Table 35. Global Immune Drugs Sales Growth Rate by Application (2019-2024)
Table 36. Global Immune Drugs Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Immune Drugs Sales Market Share by Region (2019-2024)
Table 38. North America Immune Drugs Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Immune Drugs Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Immune Drugs Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Immune Drugs Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Immune Drugs Sales by Region (2019-2024) & (Kilotons)
Table 43. Antares Pharma, Inc. Immune Drugs Basic Information
Table 44. Antares Pharma, Inc. Immune Drugs Product Overview
Table 45. Antares Pharma, Inc. Immune Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Antares Pharma, Inc. Business Overview
Table 47. Antares Pharma, Inc. Immune Drugs SWOT Analysis
Table 48. Antares Pharma, Inc. Recent Developments
Table 49. UCB Immune Drugs Basic Information
Table 50. UCB Immune Drugs Product Overview
Table 51. UCB Immune Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. UCB Business Overview
Table 53. UCB Immune Drugs SWOT Analysis
Table 54. UCB Recent Developments
Table 55. Incyte Immune Drugs Basic Information
Table 56. Incyte Immune Drugs Product Overview
Table 57. Incyte Immune Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Incyte Immune Drugs SWOT Analysis
Table 59. Incyte Business Overview
Table 60. Incyte Recent Developments
Table 61. GSK Immune Drugs Basic Information
Table 62. GSK Immune Drugs Product Overview
Table 63. GSK Immune Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. GSK Business Overview
Table 65. GSK Recent Developments
Table 66. Takeda Immune Drugs Basic Information
Table 67. Takeda Immune Drugs Product Overview
Table 68. Takeda Immune Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Takeda Business Overview
Table 70. Takeda Recent Developments
Table 71. 3S Bio Immune Drugs Basic Information
Table 72. 3S Bio Immune Drugs Product Overview
Table 73. 3S Bio Immune Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. 3S Bio Business Overview
Table 75. 3S Bio Recent Developments
Table 76. Horizon Therapeutics Immune Drugs Basic Information
Table 77. Horizon Therapeutics Immune Drugs Product Overview
Table 78. Horizon Therapeutics Immune Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Horizon Therapeutics Business Overview
Table 80. Horizon Therapeutics Recent Developments
Table 81. Bristol-Myers Squibb (BMS Immune Drugs Basic Information
Table 82. Bristol-Myers Squibb (BMS Immune Drugs Product Overview
Table 83. Bristol-Myers Squibb (BMS Immune Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Bristol-Myers Squibb (BMS Business Overview
Table 85. Bristol-Myers Squibb (BMS Recent Developments
Table 86. Astellas Immune Drugs Basic Information
Table 87. Astellas Immune Drugs Product Overview
Table 88. Astellas Immune Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Astellas Business Overview
Table 90. Astellas Recent Developments
Table 91. Eli Lilly Immune Drugs Basic Information
Table 92. Eli Lilly Immune Drugs Product Overview
Table 93. Eli Lilly Immune Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Eli Lilly Business Overview
Table 95. Eli Lilly Recent Developments
Table 96. Mitsubishi Tanabe Pharma Immune Drugs Basic Information
Table 97. Mitsubishi Tanabe Pharma Immune Drugs Product Overview
Table 98. Mitsubishi Tanabe Pharma Immune Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Mitsubishi Tanabe Pharma Business Overview
Table 100. Mitsubishi Tanabe Pharma Recent Developments
Table 101. Biogen Immune Drugs Basic Information
Table 102. Biogen Immune Drugs Product Overview
Table 103. Biogen Immune Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Biogen Business Overview
Table 105. Biogen Recent Developments
Table 106. Pfizer Immune Drugs Basic Information
Table 107. Pfizer Immune Drugs Product Overview
Table 108. Pfizer Immune Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Pfizer Business Overview
Table 110. Pfizer Recent Developments
Table 111. Sanofi Immune Drugs Basic Information
Table 112. Sanofi Immune Drugs Product Overview
Table 113. Sanofi Immune Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Sanofi Business Overview
Table 115. Sanofi Recent Developments
Table 116. Roche Immune Drugs Basic Information
Table 117. Roche Immune Drugs Product Overview
Table 118. Roche Immune Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Roche Business Overview
Table 120. Roche Recent Developments
Table 121. Novartis Immune Drugs Basic Information
Table 122. Novartis Immune Drugs Product Overview
Table 123. Novartis Immune Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Novartis Business Overview
Table 125. Novartis Recent Developments
Table 126. Johnson and Johnson (JandJ) Immune Drugs Basic Information
Table 127. Johnson and Johnson (JandJ) Immune Drugs Product Overview
Table 128. Johnson and Johnson (JandJ) Immune Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. Johnson and Johnson (JandJ) Business Overview
Table 130. Johnson and Johnson (JandJ) Recent Developments
Table 131. Amgen Immune Drugs Basic Information
Table 132. Amgen Immune Drugs Product Overview
Table 133. Amgen Immune Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 134. Amgen Business Overview
Table 135. Amgen Recent Developments
Table 136. Abbvi Immune Drugs Basic Information
Table 137. Abbvi Immune Drugs Product Overview
Table 138. Abbvi Immune Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 139. Abbvi Business Overview
Table 140. Abbvi Recent Developments
Table 141. Global Immune Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 142. Global Immune Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 143. North America Immune Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 144. North America Immune Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 145. Europe Immune Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 146. Europe Immune Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 147. Asia Pacific Immune Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 148. Asia Pacific Immune Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 149. South America Immune Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 150. South America Immune Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 151. Middle East and Africa Immune Drugs Consumption Forecast by Country (2025-2030) & (Units)
Table 152. Middle East and Africa Immune Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 153. Global Immune Drugs Sales Forecast by Type (2025-2030) & (Kilotons)
Table 154. Global Immune Drugs Market Size Forecast by Type (2025-2030) & (M USD)
Table 155. Global Immune Drugs Price Forecast by Type (2025-2030) & (USD/Ton)
Table 156. Global Immune Drugs Sales (Kilotons) Forecast by Application (2025-2030)
Table 157. Global Immune Drugs Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Immune Drugs Market Size Comparison by Region (M USD)
Table 5. Global Immune Drugs Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Immune Drugs Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Immune Drugs Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Immune Drugs Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immune Drugs as of 2022)
Table 10. Global Market Immune Drugs Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Immune Drugs Sales Sites and Area Served
Table 12. Manufacturers Immune Drugs Product Type
Table 13. Global Immune Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Immune Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Immune Drugs Market Challenges
Table 22. Global Immune Drugs Sales by Type (Kilotons)
Table 23. Global Immune Drugs Market Size by Type (M USD)
Table 24. Global Immune Drugs Sales (Kilotons) by Type (2019-2024)
Table 25. Global Immune Drugs Sales Market Share by Type (2019-2024)
Table 26. Global Immune Drugs Market Size (M USD) by Type (2019-2024)
Table 27. Global Immune Drugs Market Size Share by Type (2019-2024)
Table 28. Global Immune Drugs Price (USD/Ton) by Type (2019-2024)
Table 29. Global Immune Drugs Sales (Kilotons) by Application
Table 30. Global Immune Drugs Market Size by Application
Table 31. Global Immune Drugs Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Immune Drugs Sales Market Share by Application (2019-2024)
Table 33. Global Immune Drugs Sales by Application (2019-2024) & (M USD)
Table 34. Global Immune Drugs Market Share by Application (2019-2024)
Table 35. Global Immune Drugs Sales Growth Rate by Application (2019-2024)
Table 36. Global Immune Drugs Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Immune Drugs Sales Market Share by Region (2019-2024)
Table 38. North America Immune Drugs Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Immune Drugs Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Immune Drugs Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Immune Drugs Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Immune Drugs Sales by Region (2019-2024) & (Kilotons)
Table 43. Antares Pharma, Inc. Immune Drugs Basic Information
Table 44. Antares Pharma, Inc. Immune Drugs Product Overview
Table 45. Antares Pharma, Inc. Immune Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Antares Pharma, Inc. Business Overview
Table 47. Antares Pharma, Inc. Immune Drugs SWOT Analysis
Table 48. Antares Pharma, Inc. Recent Developments
Table 49. UCB Immune Drugs Basic Information
Table 50. UCB Immune Drugs Product Overview
Table 51. UCB Immune Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. UCB Business Overview
Table 53. UCB Immune Drugs SWOT Analysis
Table 54. UCB Recent Developments
Table 55. Incyte Immune Drugs Basic Information
Table 56. Incyte Immune Drugs Product Overview
Table 57. Incyte Immune Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Incyte Immune Drugs SWOT Analysis
Table 59. Incyte Business Overview
Table 60. Incyte Recent Developments
Table 61. GSK Immune Drugs Basic Information
Table 62. GSK Immune Drugs Product Overview
Table 63. GSK Immune Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. GSK Business Overview
Table 65. GSK Recent Developments
Table 66. Takeda Immune Drugs Basic Information
Table 67. Takeda Immune Drugs Product Overview
Table 68. Takeda Immune Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Takeda Business Overview
Table 70. Takeda Recent Developments
Table 71. 3S Bio Immune Drugs Basic Information
Table 72. 3S Bio Immune Drugs Product Overview
Table 73. 3S Bio Immune Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. 3S Bio Business Overview
Table 75. 3S Bio Recent Developments
Table 76. Horizon Therapeutics Immune Drugs Basic Information
Table 77. Horizon Therapeutics Immune Drugs Product Overview
Table 78. Horizon Therapeutics Immune Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Horizon Therapeutics Business Overview
Table 80. Horizon Therapeutics Recent Developments
Table 81. Bristol-Myers Squibb (BMS Immune Drugs Basic Information
Table 82. Bristol-Myers Squibb (BMS Immune Drugs Product Overview
Table 83. Bristol-Myers Squibb (BMS Immune Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Bristol-Myers Squibb (BMS Business Overview
Table 85. Bristol-Myers Squibb (BMS Recent Developments
Table 86. Astellas Immune Drugs Basic Information
Table 87. Astellas Immune Drugs Product Overview
Table 88. Astellas Immune Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Astellas Business Overview
Table 90. Astellas Recent Developments
Table 91. Eli Lilly Immune Drugs Basic Information
Table 92. Eli Lilly Immune Drugs Product Overview
Table 93. Eli Lilly Immune Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Eli Lilly Business Overview
Table 95. Eli Lilly Recent Developments
Table 96. Mitsubishi Tanabe Pharma Immune Drugs Basic Information
Table 97. Mitsubishi Tanabe Pharma Immune Drugs Product Overview
Table 98. Mitsubishi Tanabe Pharma Immune Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Mitsubishi Tanabe Pharma Business Overview
Table 100. Mitsubishi Tanabe Pharma Recent Developments
Table 101. Biogen Immune Drugs Basic Information
Table 102. Biogen Immune Drugs Product Overview
Table 103. Biogen Immune Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Biogen Business Overview
Table 105. Biogen Recent Developments
Table 106. Pfizer Immune Drugs Basic Information
Table 107. Pfizer Immune Drugs Product Overview
Table 108. Pfizer Immune Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Pfizer Business Overview
Table 110. Pfizer Recent Developments
Table 111. Sanofi Immune Drugs Basic Information
Table 112. Sanofi Immune Drugs Product Overview
Table 113. Sanofi Immune Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Sanofi Business Overview
Table 115. Sanofi Recent Developments
Table 116. Roche Immune Drugs Basic Information
Table 117. Roche Immune Drugs Product Overview
Table 118. Roche Immune Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Roche Business Overview
Table 120. Roche Recent Developments
Table 121. Novartis Immune Drugs Basic Information
Table 122. Novartis Immune Drugs Product Overview
Table 123. Novartis Immune Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Novartis Business Overview
Table 125. Novartis Recent Developments
Table 126. Johnson and Johnson (JandJ) Immune Drugs Basic Information
Table 127. Johnson and Johnson (JandJ) Immune Drugs Product Overview
Table 128. Johnson and Johnson (JandJ) Immune Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. Johnson and Johnson (JandJ) Business Overview
Table 130. Johnson and Johnson (JandJ) Recent Developments
Table 131. Amgen Immune Drugs Basic Information
Table 132. Amgen Immune Drugs Product Overview
Table 133. Amgen Immune Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 134. Amgen Business Overview
Table 135. Amgen Recent Developments
Table 136. Abbvi Immune Drugs Basic Information
Table 137. Abbvi Immune Drugs Product Overview
Table 138. Abbvi Immune Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 139. Abbvi Business Overview
Table 140. Abbvi Recent Developments
Table 141. Global Immune Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 142. Global Immune Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 143. North America Immune Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 144. North America Immune Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 145. Europe Immune Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 146. Europe Immune Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 147. Asia Pacific Immune Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 148. Asia Pacific Immune Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 149. South America Immune Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 150. South America Immune Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 151. Middle East and Africa Immune Drugs Consumption Forecast by Country (2025-2030) & (Units)
Table 152. Middle East and Africa Immune Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 153. Global Immune Drugs Sales Forecast by Type (2025-2030) & (Kilotons)
Table 154. Global Immune Drugs Market Size Forecast by Type (2025-2030) & (M USD)
Table 155. Global Immune Drugs Price Forecast by Type (2025-2030) & (USD/Ton)
Table 156. Global Immune Drugs Sales (Kilotons) Forecast by Application (2025-2030)
Table 157. Global Immune Drugs Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Immune Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Immune Drugs Market Size (M USD), 2019-2030
Figure 5. Global Immune Drugs Market Size (M USD) (2019-2030)
Figure 6. Global Immune Drugs Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Immune Drugs Market Size by Country (M USD)
Figure 11. Immune Drugs Sales Share by Manufacturers in 2023
Figure 12. Global Immune Drugs Revenue Share by Manufacturers in 2023
Figure 13. Immune Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Immune Drugs Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Immune Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Immune Drugs Market Share by Type
Figure 18. Sales Market Share of Immune Drugs by Type (2019-2024)
Figure 19. Sales Market Share of Immune Drugs by Type in 2023
Figure 20. Market Size Share of Immune Drugs by Type (2019-2024)
Figure 21. Market Size Market Share of Immune Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Immune Drugs Market Share by Application
Figure 24. Global Immune Drugs Sales Market Share by Application (2019-2024)
Figure 25. Global Immune Drugs Sales Market Share by Application in 2023
Figure 26. Global Immune Drugs Market Share by Application (2019-2024)
Figure 27. Global Immune Drugs Market Share by Application in 2023
Figure 28. Global Immune Drugs Sales Growth Rate by Application (2019-2024)
Figure 29. Global Immune Drugs Sales Market Share by Region (2019-2024)
Figure 30. North America Immune Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Immune Drugs Sales Market Share by Country in 2023
Figure 32. U.S. Immune Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Immune Drugs Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Immune Drugs Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Immune Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Immune Drugs Sales Market Share by Country in 2023
Figure 37. Germany Immune Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Immune Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Immune Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Immune Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Immune Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Immune Drugs Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Immune Drugs Sales Market Share by Region in 2023
Figure 44. China Immune Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Immune Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Immune Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Immune Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Immune Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Immune Drugs Sales and Growth Rate (Kilotons)
Figure 50. South America Immune Drugs Sales Market Share by Country in 2023
Figure 51. Brazil Immune Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Immune Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Immune Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Immune Drugs Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Immune Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Immune Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Immune Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Immune Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Immune Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Immune Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Immune Drugs Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Immune Drugs Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Immune Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Immune Drugs Market Share Forecast by Type (2025-2030)
Figure 65. Global Immune Drugs Sales Forecast by Application (2025-2030)
Figure 66. Global Immune Drugs Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Immune Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Immune Drugs Market Size (M USD), 2019-2030
Figure 5. Global Immune Drugs Market Size (M USD) (2019-2030)
Figure 6. Global Immune Drugs Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Immune Drugs Market Size by Country (M USD)
Figure 11. Immune Drugs Sales Share by Manufacturers in 2023
Figure 12. Global Immune Drugs Revenue Share by Manufacturers in 2023
Figure 13. Immune Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Immune Drugs Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Immune Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Immune Drugs Market Share by Type
Figure 18. Sales Market Share of Immune Drugs by Type (2019-2024)
Figure 19. Sales Market Share of Immune Drugs by Type in 2023
Figure 20. Market Size Share of Immune Drugs by Type (2019-2024)
Figure 21. Market Size Market Share of Immune Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Immune Drugs Market Share by Application
Figure 24. Global Immune Drugs Sales Market Share by Application (2019-2024)
Figure 25. Global Immune Drugs Sales Market Share by Application in 2023
Figure 26. Global Immune Drugs Market Share by Application (2019-2024)
Figure 27. Global Immune Drugs Market Share by Application in 2023
Figure 28. Global Immune Drugs Sales Growth Rate by Application (2019-2024)
Figure 29. Global Immune Drugs Sales Market Share by Region (2019-2024)
Figure 30. North America Immune Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Immune Drugs Sales Market Share by Country in 2023
Figure 32. U.S. Immune Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Immune Drugs Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Immune Drugs Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Immune Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Immune Drugs Sales Market Share by Country in 2023
Figure 37. Germany Immune Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Immune Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Immune Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Immune Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Immune Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Immune Drugs Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Immune Drugs Sales Market Share by Region in 2023
Figure 44. China Immune Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Immune Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Immune Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Immune Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Immune Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Immune Drugs Sales and Growth Rate (Kilotons)
Figure 50. South America Immune Drugs Sales Market Share by Country in 2023
Figure 51. Brazil Immune Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Immune Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Immune Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Immune Drugs Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Immune Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Immune Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Immune Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Immune Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Immune Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Immune Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Immune Drugs Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Immune Drugs Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Immune Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Immune Drugs Market Share Forecast by Type (2025-2030)
Figure 65. Global Immune Drugs Sales Forecast by Application (2025-2030)
Figure 66. Global Immune Drugs Market Share Forecast by Application (2025-2030)
